Metabolic Solutions Development Company Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Metabolic Solutions Development Company General Information
Description
Developer of a novel molecular target and therapeutics designed to treat diabetes and related symptoms of metabolic syndrome. The company's therapeutics provide drugs that treat metabolic diseases associated with age-related mitochondrial dysfunction, including insulin resistance and type 2 diabetes through modulated mitochondrial control of important cellular activities, such as carbohydrate, lipid, and amino acid metabolism, enabling diabetic patients to get insulin sensitizers.
Contact Information
Website
www.msdrx.comCorporate Office
- 161 East Michigan Avenue
- 4th Floor
- Kalamazoo, MI 49007
- United States
Corporate Office
- 161 East Michigan Avenue
- 4th Floor
- Kalamazoo, MI 49007
- United States
Metabolic Solutions Development Company Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 12. Later Stage VC | 05-Feb-2019 | Completed | Clinical Trials - Phase 2 | |||
| 11. Grant | 01-Jan-2014 | Completed | Clinical Trials - Phase 2 | |||
| 10. Grant | 06-Oct-2011 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC | 10-Aug-2011 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 06-Jul-2011 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC (Series D) | 21-Oct-2010 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 01-Jan-2010 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC | 30-Apr-2009 | $10.6M | $26.4M | Completed | Clinical Trials - Phase 2 | |
| 4. Grant | 01-Jan-2009 | $381K | $15.8M | Completed | Clinical Trials - Phase 2 |
Metabolic Solutions Development Company Comparisons
Industry
Financing
Details
Metabolic Solutions Development Company Competitors (107)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Navitor Pharmaceuticals | Venture Capital-Backed | Cambridge, MA | ||||
| Verona Pharma | Private Debt Financed | London, United Kingdom | ||||
| Promentis Pharmaceuticals | Venture Capital-Backed | Milwaukee, WI | ||||
| Viriom | Venture Capital-Backed | Rockville, MD | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA |
Metabolic Solutions Development Company Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Metabolic Solutions Development Company Patents
Metabolic Solutions Development Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014293405-A1 | Ppar-sparing compounds for the treatment of metabolic diseases | Active | 22-Jul-2013 | ||
| AU-2014293405-B2 | Ppar-sparing compounds for the treatment of metabolic diseases | Active | 22-Jul-2013 | ||
| CA-2918376-A1 | Ppar-sparing compounds for the treatment of metabolic diseases | Active | 22-Jul-2013 | ||
| ES-2813363-T3 | Ppar-sparing compounds for the treatment of metabolic diseases | Active | 22-Jul-2013 | ||
| EP-3024816-B1 | Ppar-sparing compounds for the treatment of metabolic diseases | Active | 22-Jul-2013 | C07D213/68 |
Metabolic Solutions Development Company Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| Rolf Kletzien Ph.D | Co-Founder & Board Member | |
| James VanderLugt MD | Chief Medical Officer | |
| Stephen Benoit | Chief Executive Officer & Board Member | |
| Jerry Colca Ph.D | Co-Founder, Board Member, President & Chief Scientific Officer |
Metabolic Solutions Development Company Board Members (10)
| Name | Representing | Role | Since |
|---|---|---|---|
| Angeline Shashlo | Self | Board Member | |
| Gerald Callahan Ph.D | Michigan Accelerator Fund 1 | Board Member | |
| James Schultz JD | Open Prairie Ventures | Board Member | |
| Mark Olesnavage | Hopen Life Science Ventures | Chairman | |
| Michael Jandernoa | Hopen Life Science Ventures | Board Member |
Metabolic Solutions Development Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Metabolic Solutions Development Company Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute of Alcohol Abuse and Alcoholism | Government | |||
| National Institute of Diabetes and Digestive and Kidney Diseases | Government | |||
| Charter Growth Capital | Mezzanine | |||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | |||
| U.S. Department of Health and Human Services | Government |
Metabolic Solutions Development Company FAQs
-
When was Metabolic Solutions Development Company founded?
Metabolic Solutions Development Company was founded in 2006.
-
Who is the founder of Metabolic Solutions Development Company?
Rolf Kletzien Ph.D and Jerry Colca Ph.D are the founders of Metabolic Solutions Development Company.
-
Who is the CEO of Metabolic Solutions Development Company?
Stephen Benoit is the CEO of Metabolic Solutions Development Company.
-
Where is Metabolic Solutions Development Company headquartered?
Metabolic Solutions Development Company is headquartered in Kalamazoo, MI.
-
What is the size of Metabolic Solutions Development Company?
Metabolic Solutions Development Company has 13 total employees.
-
What industry is Metabolic Solutions Development Company in?
Metabolic Solutions Development Company’s primary industry is Drug Discovery.
-
Is Metabolic Solutions Development Company a private or public company?
Metabolic Solutions Development Company is a Private company.
-
What is Metabolic Solutions Development Company’s current revenue?
The current revenue for Metabolic Solutions Development Company is .
-
How much funding has Metabolic Solutions Development Company raised over time?
Metabolic Solutions Development Company has raised $73M.
-
Who are Metabolic Solutions Development Company’s investors?
National Institute of Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases, Charter Growth Capital, Alzheimers Drug Discovery Foundation, and U.S. Department of Health and Human Services are 5 of 7 investors who have invested in Metabolic Solutions Development Company.
-
Who are Metabolic Solutions Development Company’s competitors?
Navitor Pharmaceuticals, Verona Pharma, Promentis Pharmaceuticals, Viriom, and Alnylam Pharmaceuticals are some of the 107 competitors of Metabolic Solutions Development Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
